Kátia Sheylla Malta Purim1, Murilo Calvo Peretti2, José Fillus3, Marcia Olandoski4. 1. Discipline of Dermatology of the Medical School - Universidade Positivo (UP) - Curitiba (PR), Brazil. 2. Dermatology Service of theHospital das Clínicas - Universidade Federal do Paraná (HC-UFPR) - Curitiba (PR), Brazil. 3. Dermatology Service of the Hospital Evangélico de Curitiba - Universidade Evangélica do Paraná - Curitiba (PR), Brazil. 4. Discipline of Biostatistics of the Medical School - Pontifícia Universidade Católica do Paraná (PUC-PR) - Curitiba (PR), Brazil.
Abstract
BACKGROUND: : Histological and mycological changes during itraconazole use have not been totally established in chromoblastomycosis. OBJECTIVES: : To evaluate tissue modifications in chromoblastomycosis carriers under itraconazole treatment. METHODS: : A histological retrospective study of 20 cases of chromoblastomycosis seen at the university hospital at the south of Brazil, during itraconazole 400 mg daily treatment. Patients were classified into two groups: plaque or tumor lesions, and underwent periodic evaluations every four months during three years. Hematoxylin-eosin stain was used to analyze epidermal modifications, inflammatory infiltrate and fibrosis, and Fontana-Masson stain for parasite evaluation. RESULTS: : Fontana-Masson stain was superior to hematoxylin-eosin stain in fungal count in the epidermis (mean difference=0.14; p<0.05). The most distinct mycosis tissue responses were registered in the dermis. Epidermal thinning, granulomatous infiltrate decrease or disappearance, fibrosis increase and quantitative/morphological changes occurred during treatment. STUDY LIMITATIONS:: Patients could not be located to have their current skin condition examined. CONCLUSION: : Parasitic and tissue changes verified in this study can reflect the parasite-host dynamics under itraconazole action.
BACKGROUND: : Histological and mycological changes during itraconazole use have not been totally established in chromoblastomycosis. OBJECTIVES: : To evaluate tissue modifications in chromoblastomycosis carriers under itraconazole treatment. METHODS: : A histological retrospective study of 20 cases of chromoblastomycosis seen at the university hospital at the south of Brazil, during itraconazole 400 mg daily treatment. Patients were classified into two groups: plaque or tumor lesions, and underwent periodic evaluations every four months during three years. Hematoxylin-eosin stain was used to analyze epidermal modifications, inflammatory infiltrate and fibrosis, and Fontana-Masson stain for parasite evaluation. RESULTS: : Fontana-Masson stain was superior to hematoxylin-eosin stain in fungal count in the epidermis (mean difference=0.14; p<0.05). The most distinct mycosis tissue responses were registered in the dermis. Epidermal thinning, granulomatous infiltrate decrease or disappearance, fibrosis increase and quantitative/morphological changes occurred during treatment. STUDY LIMITATIONS:: Patients could not be located to have their current skin condition examined. CONCLUSION: : Parasitic and tissue changes verified in this study can reflect the parasite-host dynamics under itraconazole action.
Chromoblastomycosis is a chronic disease caused by dematiaceus fungi found in soil
and decaying vegetation, common in tropical and subtropical regions.[1-3] Infection occurs by traumatic fungal inoculation into the skin,
and mycosis is very prevalent in rural men.[4-6] It is characterized
by lesions of polymorphic, papillomatous, nodular, cauliflower, verruciform,
hyperkeratotic, cicatricial, plaque or combinations, in the lower limbs, with no
tendency to spontaneous cure (Figure
1).[7]
Figure 1
Clinical aspect of tumoral lesion with papillomatous surface, covered by
black dots (arrow), on the dorsum of left foot
Clinical aspect of tumoral lesion with papillomatous surface, covered by
black dots (arrow), on the dorsum of left footChronic inflammatory infiltrate, microabscesses, dark-brown parasites and
granulomatous process are frequent findings in histopathology.[8] Suppurative granuloma rich in fungal
cells is almost always observed in verrucous lesions, while tuberculoid granulomas
with few parasites are mainly detected in cicatricial lesions and well-defined
erythematous plaques, suggesting that verrucous lesions have a less competent
tecidual inflammatory response.[9]
The muriform element is pathognomonic and observed in tissue biopsy specimens or by
direct mycological examination from black dotted scrapings of the cutaneous lesion
with 10% KOH.[10]Little is known about histological alterations and variation of the positivity of
mycological exams resulting from systemic treatments with antifungals. This study
aims to analyze tissue changes during therapy with itraconazole.
METHODS
This is a histological study of cases of chromoblastomycosis from clinical research
performed at a university hospital in the Southern region of Brazil.[11,12] Patients were submitted to at least four biopsies of
cutaneous lesions - one biopsy to diagnose the disease and a minimum of three
biopsies to follow the tissue modifications during the treatment. Periodic
evaluation occurred every four months, and participants were followed for three
years from 1988 to 1991. The project to access this historical documentation was
approved by the Ethics Committee (protocol 10835/2012).Skin biopsies, always conducted by the same researcher, consisted of an ellipse of
1cm of tissue on the largest axis, composed of epidermis, dermis and hypodermis, and
were intended for mycological and histopathological study. In active lesions,
biopsies were collected in regions of black dotted and/or erythematous borders. In
healed lesions during treatment, biopsy was obtained from its border, and
desquamative areas with granular appearance were selected. Hematoxylin-eosin (HE)
staining was used to verify tissue changes, and HE and Fontana-Masson (FM) staining
was used to evaluate fungi throughout the treatment (Chart 1). For the direct mycological examination, 10% KOH solution was
used and, for culture, Sabouraud agar medium.
Chart 1
Stainings used in cases of chromoblastomycosis and their purposes in the
course of treatment with itraconazole
STAINING
PURPOSE
Hematoxylin-eosin
Analysis of tissue
modifications
Definition of the degree of tissue
changes
Epidermis
Morphology
E1:
Atrophy: decreased epidermal thickness with loss of
papillary pattern
E2:
Hyperplasia: increased number of epidermal cells
E3:
Pseudoepitheliomatous hyperplasia: increased cell
numbers, thickening of the epidermis, rare mitoses without loss of
polarity and elongation of the epithelial cones with epidermal
shoots within the dermis
Dermis
Inflammatory infiltrate
D1:
Local lymphoplasmo-histiocytic
D2:
Lymphoplasmo-histiocytic and mononuclear with sparse
granulomas
D3:
Lymphoplasmo-histiocytic, polymorphonuclear and
mononuclear with various granulomas and microabscesses
Hipodermis
Tissue fibrosis
F1:
Predominantly in hypodermis
F2:
Predominantly in hypodermis and reticular dermis
F3:
In hypodermis, reticular and papillary dermis
Fontana- Masson
Parasite analysis in host
tissue
Distribution of fungi in the epidermis,
dermis and hypodermis and visualization of their aspects
Stainings used in cases of chromoblastomycosis and their purposes in the
course of treatment with itraconazoleFungus count occurred on two slides, one stained by HE and the other stained by FM.
Counting started always in the upper left corner of the slides, moving the chariot
from top to bottom in the epidermis-hypodermic direction until the end of the
histological section. Then the chariot was moved from left to right relative to the
observer, moving a field at right angle and resuming the count from the bottom up in
the hypodermis-epidermis direction. American Optical Spencer microscope was used,
with a 40x objective lens and a 10x ocular lens. In the slides with more than one
histological section, stained by HE, the section closest to the slide label, to the
left of the observer, was used. A reticle was adapted to the 10WF CAT 176 AO ocular
lens to delineate areas of histological sections for counting.In each slide, 100 reticulated areas were counted, registering only the spherical
integral parasitic elements found in the odd-numbered reticulated areas. In order to
avoid registering a parasite more than once, the following rule was adopted: the
parasite that was located on the border lines of the reticulated area, left and
above, was counted for this field. The parasite that was situated on the right and
below did not belong to this field. For record purposes, each parasitic element
found with or without septation, isolated or clustered, was equivalent to one unit.
Artifact pigments, fragmented structures and hyphae were excluded from counting.Criteria used to control the treatment were: clinical (complete healing of all
lesions), mycological (absence of parasites at the direct mycological examination
and culture) and histological (absence of parasites, absence of microabscesses,
atrophy of the epidermis, replacement of the active granulomatous infiltrate in the
dermis due to chronic inflammatory infiltrate and dense fibrosis).In the statistical analysis, Kappa coefficients were estimated and 95% confidence
intervals were used to evaluate the concordance between mycological, histological
and culture examinations. For the comparison of the HE and FM stainings, Student's
t-test was used for paired samples. Comparison between tumor manifestation and
plaque manifestation, in relation to the probability of having a clinical
improvement or cure as final result, was performed using Fisher's exact test. For
this same analysis, the relative risk was estimated. Values of p<0.05 indicated
statistical significance. Data were analyzed using IBM SPSS Statistics v.20
software.
RESULTS
The sample consisted of 20 individuals, white, adults, farmers, 17 of them were men,
with mean age of 58.2 years and standard deviation of 11.1 years (42 to 82 years)
and 3 women aged 33 to 54 years (mean age of 41.6 and standard deviation of 11.0
years), all receiving treatment with itraconazole 200-400 mg/day. During the study,
135 skin biopsies were performed with a mean of 6.7 biopsies/patient.Prior to treatment, direct mycological examination was positive in 80% of cases;
culture in 85%; and histological examination, in 100% (Figure 2). Culture and microculture allowed the identification of
F. pedrosoi in 100% of the patients (Figure 3). During follow-up, there was a good level of
concordance between mycological (direct and culture) and histopathological
examination (Kappa: 0.64; 95% CI: 0.51 to 0.76); between culture and direct
mycological examination (Kappa: 0.67, 95% CI 0.55 to 0.80); and between culture and
histopathological examination (Kappa: 0.71, 95% CI: 0.59 to 0.84).
Figure 2
Positive direct mycological examination: brown spherical parasite
elements, with and without septation, observed on tissue fragment with
KOH (x1000)
Figure 3
A) Colony morphology of Fonsecaea pedrosoi
in Sabouraud-dextrose-agar medium after 21 days of incubation;
B) Microculture of Fonsecaea pedrosoi
(X1000)
Positive direct mycological examination: brown spherical parasite
elements, with and without septation, observed on tissue fragment with
KOH (x1000)A) Colony morphology of Fonsecaea pedrosoi
in Sabouraud-dextrose-agar medium after 21 days of incubation;
B) Microculture of Fonsecaea pedrosoi
(X1000)Tissue modifications of the skin during treatment with itraconazole were significant
in the epidermis, dermis and hypodermis when the results of the baseline evaluation
(month 0) were compared with the results observed in the period from 9 to 12 months
after treatment. In the comparison between the baseline and the 4 to 8 months
period, the results indicated significant differences for the epidermis and dermis,
with a tendency towards significance for fibrosis. Between the period of 4 to 8
months and the period of 9 to 12 months, a significant difference was found for the
intensity of fibrosis (Table 1).
Table 1
Comparison of two types of scars
Evaluation phase (month)
Epidermis morphology
Dermal inflammatory infiltrate
Fibrosis intensity
E1+E2
E3
D1+D2
D3
F1
F2+F3
0
5 (25%)
15 (75%)
5 (25%)
15 (75%)
20 (100%)
0 (0%)
4 to 8
14 (70%)
6 (30%)
14 (70%)
6 (30%)
15 (75%)
5 (25%)
9 to 12
18 (90%)
2 (10%)
17 (85%)
3 (15%)
8 (40%)
12 (60%)
Compared phases
P value
P value
P value
0 x 4 to 8
0.004
0.004
0.062
0 x 9 to 12
<0.001
<0.001
<0.001
4 to 8 x 9 to 12
0.125
0.250
0.016
Comparison of two types of scarsFigure 4 illustrates histological aspect prior
to treatment. Figure 5 shows parasitic elements
in the middle of the dermal inflammatory infiltrate.
A) Septated parasitic elements in the middle of the
suppurative and granulomatous inflammatory infiltrate (Hematoxylin &
eosin, X1000); B) Parasitic elements with signs of
degeneration (arrow) in the middle of the inflammatory infiltrate
(Hematoxylin & eosin, X40)
Pretreatment histological aspect: hyperkeratosis, pseudoepitheliomatous
hyperplasia and dermal inflammatory infiltrate (Hematoxylin & eosin,
X40)A) Septated parasitic elements in the middle of the
suppurative and granulomatous inflammatory infiltrate (Hematoxylin &
eosin, X1000); B) Parasitic elements with signs of
degeneration (arrow) in the middle of the inflammatory infiltrate
(Hematoxylin & eosin, X40)Comparing the visualization of the fungi in the FM and HE stainings, it was verified
that their identification was facilitated by the FM staining, mainly in the
epidermis (mean difference of 0.14 fungus and standard deviation of 0.50, p<0.05)
(Figure 6).
Figure 6
A) Septated parasitic elements (arrows) in the dermis
(Fontana-Masson coloration, X40); B) Parasitic elements
(arrows) in the dermis, delimited by reticulated area for counting
(Hematoxylin & eosin, X40)
A) Septated parasitic elements (arrows) in the dermis
(Fontana-Masson coloration, X40); B) Parasitic elements
(arrows) in the dermis, delimited by reticulated area for counting
(Hematoxylin & eosin, X40)In the final evaluation, of the 11 patients with tumor manifestation, 9 (82%)
presented improvement or clinical cure and 2 (18%) presented clinical and biological
cure. Of the 9 patients with plaque manifestations, 3 (33%) presented improvement or
clinical cure and the other 6 (67%) presented clinical and biological cure (p =
0.065). Therefore, it is estimated that, for cases with tumor manifestation, the
relative risk of having clinical improvement or cure (and not clinical and
biological cure) is 2.5 times, when compared with cases with plaque
manifestation.
DISCUSSION
In this study, before the institution of the treatment, the direct mycological
examination was positive in 80% of the cases; culture in 85%; and histological
examination in 100%. As the mycosis presents centrifugal growth, choosing areas of
black dotted region and active lesions borders or, in the absence of these borders,
of cicatrized lesions guided the investigation of fungi, which allowed equivalence
between the positivity of the mycological and histological exams. Culture and
microculture allowed the identification of F. pedrosoi as an
etiological agent of all cases, according to the literature.[8,13-16]In chromoblastomycosis, the tissue response to the fungus is non-specific and may be
similar to other deep mycoses. Most epidermal tissue alterations on
histopathological examination are hyperkeratosis and pseudoepitheliomatous
hyperplasia. In dermal and hypodermal tissues, non-specific diffuse inflammatory
infiltrates are detected.[17] Other
findings include suppurative and granulomatous reactions, sclerotic bodies and
acanthosis with transepidermal fungal elimination.[3,18-22] In this study, the intensity and
type of histological response were modified according to patient and therapeutic
phase. Before treatment, there was a tendency to an exuberant inflammatory
condition, epidermis with hyperkeratosis, parakeratosis, leukocyte crusts,
Malpighian layer acanthosis, spongiosis, neutrophil and eosinophil exocytosis and
microabscesses. Acanthosis was irregular, with typical cells and hypertrophy of the
papillae protruding above the cutaneous surface, with enlargement and bifurcation of
the interpapillary ridges, constituting pseudoepitheliomatous hyperplasia.The most distinct alterations in this study were found in the dermis. Before
treatment, hyperplasia, papillomatosis, vascular neoformation and dilations, and
edema were noted. The cellular infiltrate combined suppurative and granulomatous
foci, being the parasites found amidst the inflammatory response or inside giant
cells. The stratum corneum microabscesses probably corresponded to the black dots,
observed macroscopically in the skin surface, resulting from transepithelial
elimination and from the presence of dermoepidermal fistulas draining outwards.
Throughout the treatment, there was progressive atrophy of the epidermis, decrease
or disappearance of the granulomatous infiltrate and increase in the degree of
fibrosis. Findings such as disappearance of microabscesses and granulomas,
disappearance of parasites to mycological exams (direct and culture) and clinical
healing of all the lesions allowed the support of the cure criteria, being able to
be used to interrupt the treatment and follow up of the cases.[23]FM staining was superior to HE staining in detecting fungi with a lighter shade,
mainly in the epidermis. Due to their natural pigmentation, these parasites are
easily identified on uncolored slides. Special stainings like FM are useful for
demonstrating hyphae in keratinized layers.[24] In general, fungi detected in the histological sections had
the following aspects: demaceous hyphae and septated spherical parasitic elements in
one plane, in two planes (muriform element) or without septation, representing the
metamorphism of the parasite, not being necessary the exclusiveness of the muriform
element for the diagnosis of the disease.In this study, the finding of hyphae in the epidermis was occasional. Parasites
presented predominantly dermal location, followed by epidermal, which could be
explained by changes in the thickness of their cell wall and decrease of the melanin
pigmentation. The location on the surface allows transformation to mycelial form.
Fungi located in the dermis undergo the phenomenon of parasitic reduction and
generally have a thicker and pigmented wall due to adverse conditions to their
parasitism: tissue pressure, local acidification and suppurative and granulomatous
inflammatory reaction. Although curious, data on parasite count would lack better
investigation, since the amount of fungi recorded was neither static nor definitive,
since the histological section represented only one plane of a process that is
essentially evolutionary and three-dimensional.There was a greater tendency for clinical improvement or cure in tumoral forms when
compared with plaque manifestation. Favorable clinical evolution during treatment
was correlated to negative mycological exams, slower growth of cultures, or
non-development of the fungus, and a predominance of histopathology with isolated
parasites, reduced in size, with a clearer cell wall, without septation and
cytoplasmic organelles, with signs of degeneration. Patients with a less favorable
clinical response were positive for mycological exams and presented predominance of
parasites with a thickened, well pigmented cell wall with a tendency to cluster,
septation and intracytoplasmic organelles, possibly resulting from an adaptive
mechanism of sclerotic bodies to escape from the body's defense.[25-28] The amount of parasites recorded did not appear to
interfere with clinical manifestation prior to treatment. However, the excessive
number of parasites and the higher frequency of transepithelial elimination in the
most exuberant cases suggest that host factors can determine the quality and
quantity of the tissue response.Limitations of this research were the absence of electron microscopy for a better
evaluation of parasitic modifications and immunological techniques for investigation
of circulating antigens that could complement the findings of the biopsies with
other more specific and sensitive methods. In addition, it was not possible to
locate the patients and verify their current skin condition, since most of them came
from rural environments in other municipalities and lost hospital follow-up.
CONCLUSION
In this study, there was a greater tendency for clinical improvement or cure of
tumoral forms when compared with plaque manifestation. There was concordance between
the positivity of mycological and histological exams during treatment. The FM
staining facilitated the demonstration of fungi in the epidermis. The most distinct
tissue responses of mycosis were recorded in the dermis, with tissue and parasitic
changes occurring during treatment with itraconazole, which may reflect
parasite-host dynamics.
Authors: Rafaela Teixeira Marinho Correia; Neusa Y S Valente; Paulo Ricardo Criado; José Eduardo da Costa Martins Journal: An Bras Dermatol Date: 2010 Jul-Aug Impact factor: 1.896
Authors: Seema V Pradhan; O P Talwar; Arnab Ghosh; Ravi M Swami; K C Shiva Raj; Sanjeev Gupta Journal: Indian J Dermatol Venereol Leprol Date: 2007 May-Jun Impact factor: 2.545
Authors: André L S Santos; Vanila F Palmeira; Sonia Rozental; Lucimar F Kneipp; Leonardo Nimrichter; Daniela S Alviano; Marcio L Rodrigues; Celuta S Alviano Journal: FEMS Microbiol Rev Date: 2007-07-23 Impact factor: 16.408
Authors: Gabriela A Giraldelli; Jéssica L C S Baka; Rosane Orofino-Costa; Juan Piñeiro-Maceira; Elisa Barcaui; Carlos B Barcaui Journal: PLoS Negl Trop Dis Date: 2022-03-03